These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1214 related items for PubMed ID: 18483486

  • 1. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells.
    Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, Brabletz T.
    EMBO Rep; 2008 Jun; 9(6):582-9. PubMed ID: 18483486
    [Abstract] [Full Text] [Related]

  • 2. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs.
    Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, Waldvogel B, Vannier C, Darling D, zur Hausen A, Brunton VG, Morton J, Sansom O, Schüler J, Stemmler MP, Herzberger C, Hopt U, Keck T, Brabletz S, Brabletz T.
    Nat Cell Biol; 2009 Dec; 11(12):1487-95. PubMed ID: 19935649
    [Abstract] [Full Text] [Related]

  • 3. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.
    Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ.
    Nat Cell Biol; 2008 May; 10(5):593-601. PubMed ID: 18376396
    [Abstract] [Full Text] [Related]

  • 4. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
    Cong N, Du P, Zhang A, Shen F, Su J, Pu P, Wang T, Zjang J, Kang C, Zhang Q.
    Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
    [Abstract] [Full Text] [Related]

  • 5. β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness.
    Sánchez-Tilló E, de Barrios O, Siles L, Cuatrecasas M, Castells A, Postigo A.
    Proc Natl Acad Sci U S A; 2011 Nov 29; 108(48):19204-9. PubMed ID: 22080605
    [Abstract] [Full Text] [Related]

  • 6. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.
    Bai WD, Ye XM, Zhang MY, Zhu HY, Xi WJ, Huang X, Zhao J, Gu B, Zheng GX, Yang AG, Jia LT.
    Int J Cancer; 2014 Sep 15; 135(6):1356-68. PubMed ID: 24615544
    [Abstract] [Full Text] [Related]

  • 7. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer.
    Schmalhofer O, Brabletz S, Brabletz T.
    Cancer Metastasis Rev; 2009 Jun 15; 28(1-2):151-66. PubMed ID: 19153669
    [Abstract] [Full Text] [Related]

  • 8. The ZEB1/miR-200c feedback loop regulates invasion via actin interacting proteins MYLK and TKS5.
    Sundararajan V, Gengenbacher N, Stemmler MP, Kleemann JA, Brabletz T, Brabletz S.
    Oncotarget; 2015 Sep 29; 6(29):27083-96. PubMed ID: 26334100
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer, and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1.
    Jin M, Yang Z, Ye W, Xu H, Hua X.
    PLoS One; 2014 Sep 29; 9(8):e103965. PubMed ID: 25090005
    [Abstract] [Full Text] [Related]

  • 11. Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes.
    Zhao S, Zhang Y, Zheng X, Tu X, Li H, Chen J, Zang Y, Zhang J.
    J Cell Physiol; 2015 Nov 29; 230(11):2706-17. PubMed ID: 25808945
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition.
    Xiong H, Hong J, Du W, Lin YW, Ren LL, Wang YC, Su WY, Wang JL, Cui Y, Wang ZH, Fang JY.
    J Biol Chem; 2012 Feb 17; 287(8):5819-32. PubMed ID: 22205702
    [Abstract] [Full Text] [Related]

  • 15. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.
    Korpal M, Lee ES, Hu G, Kang Y.
    J Biol Chem; 2008 May 30; 283(22):14910-4. PubMed ID: 18411277
    [Abstract] [Full Text] [Related]

  • 16. Targets of miR-200c mediate suppression of cell motility and anoikis resistance.
    Howe EN, Cochrane DR, Richer JK.
    Breast Cancer Res; 2011 Apr 18; 13(2):R45. PubMed ID: 21501518
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D, Guo J, Wu Y, Du J, Wang X, An J, Hu B, Kong L, Di W, Wang W.
    Theranostics; 2019 Apr 18; 9(7):2036-2055. PubMed ID: 31037155
    [Abstract] [Full Text] [Related]

  • 20. MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways.
    Li X, Roslan S, Johnstone CN, Wright JA, Bracken CP, Anderson M, Bert AG, Selth LA, Anderson RL, Goodall GJ, Gregory PA, Khew-Goodall Y.
    Oncogene; 2014 Jul 31; 33(31):4077-88. PubMed ID: 24037528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.